|
Guy Mayer was named president for RTI Biologics in February 2008. He joined Tutogen Medical as president and chief executive officer in January 2005. In his role at RTI Biologics Mayer oversees all aspects of marketing and distribution through medical device companies.
Prior to Tutogen Guy served for two years as chairman and CEO of Visen Medical a private biotech company focused on Molecular Imaging technologies. Prior to Visen he served three years as president and CEO of ETEX Corporation a private biomedical company based in Cambridge Mass. For 13 years prior to joining ETEX Mayer held various senior positions at Zimmer Inc. then a division of Bristol Myers Squibb with sales in excess of $1.2 billion.
Guy is a graduate of the University of Ottawa and currently serves on the Board of Directors of Spire Corporation a public company as well as a number of private companies. | 